Eduardo Terán/X
Jan 25, 2025, 12:41
Eduardo Terán: Disappointing results from the Phase 2 INNOVATION trial
Eduardo Terán, GI Medical Oncologist at Vall d’Hebron Barcelona Hospital, posted on X:
“Disappointing results from the Phase 2 INNOVATION trial, maybe FLOT-T is a well tolerated option to improve tumor downsizing for surgery…
Brilliant discussion by Dr. Yoon on pCR and HER2 challenges in resectable GEA.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 25, 2025, 12:41
Jan 25, 2025, 12:41
Jan 25, 2025, 12:41
Jan 25, 2025, 12:41
Jan 25, 2025, 12:41
Jan 25, 2025, 12:41
Jan 25, 2025, 12:41
Jan 25, 2025, 12:41
Jan 25, 2025, 12:41
Jan 25, 2025, 12:41